Proposal of a new grading system for malignant fibrous histiocytomas.

The proposed grading system for malignant fibrous histiocytomas (MFH) comprises 3 grades of malignancy. Analogous to other grading systems, the system includes the factors of mitotic rate and necrosis. In addition to these two factors, the concept of cellularity was included. The prognostic relevance of the grading systems published by Costa, Coindre, van Unnik, Pezzi and Tsujimoto as well as the grading system proposed by the present study was tested on 161 MFH. The results showed that all grading systems tested produced clearly significant differences (p < 0.01) with regard to the survival estimated for patients with various grades of malignancy. These results revealed the superiority of systems that use 3 grades of malignancy over a 2-grade classification. The proposed grading system yielded a lower percentage of grade II tumours (37%) than the grading systems of Coindre (60%) and van Unnik (70%). In the multivariate analysis of all grading systems, the proposed grading system was the only one to show prognostic relevance (p < 0. 05).

[1]  A. Schauer,et al.  Relevance of ploidy related parameters for prognosis in malignant fibrous histiocytomas. , 1999, Anticancer research.

[2]  E. Levine,et al.  Prognostic factors in soft tissue sarcoma. , 1999, Seminars in surgical oncology.

[3]  F. Collin,et al.  Prognostic factors for patients with localized primary malignant fibrous histiocytoma: A multicenter study of 216 patients with multivariate analysis , 1996, Cancer.

[4]  A. Pollack,et al.  Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. , 1996, International journal of radiation oncology, biology, physics.

[5]  A. Schauer,et al.  P-53 positivity and high proliferative index: factors of bad prognosis in malignant fibrous histiocytomas. , 1995, In vivo.

[6]  A. Schauer,et al.  Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histocytoma. , 1995, Anticancer research.

[7]  M. Tsuneyoshi,et al.  Prognostic significance of histologic parameters of soft tissue sarcomas , 1992, Cancer.

[8]  R. Pollock,et al.  Prognostic factors in 227 patients with malignant fibrous histiocytoma , 1992, Cancer.

[9]  O. Sneppen,et al.  Histopathological grading of soft tissue tumours. Prognostic significance in a prospective study of 278 consecutive cases , 1991, The Journal of pathology.

[10]  K. Aozasa,et al.  Multivariate analysis for histologic prognostic factors in soft tissue sarcomas , 1988, Cancer.

[11]  H. Bruch.  47. Knochen- und Weichgewebstumoren - Allgemeine Strategie der Therapie , 1987, Langenbecks Archiv für Chirurgie.

[12]  J. Coindre,et al.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma , 1986, Cancer.

[13]  S. Rosenberg,et al.  The grading of soft tissue sarcomas results of a clinicohistopathologic correlation in a series of 163 cases , 1984, Cancer.

[14]  B. Stener,et al.  A multivariate analysis of the prognosis after surgical treatment of malignant soft‐tissue tumors , 1982, Cancer.

[15]  W. Nathrath,et al.  Malignant fibrous histiocytoma: histological patterns and cell types. , 1980, Pathology, research and practice.

[16]  S. Weiss,et al.  Malignant fibrous histiocytoma. An Analysis of 200 Cases , 1978 .

[17]  S. Weiss,et al.  Myxoid variant of malignant fibrous histiocytoma , 1977, Cancer.

[18]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[19]  M. Itsuno,et al.  [Malignant fibrous histiocytoma]. , 1994, Nihon rinsho. Japanese journal of clinical medicine.

[20]  D. Dahlin.  Grading of Soft-Tissue Sarcomas , 1988 .

[21]  J. Ryan,et al.  Recent Concepts in Sarcoma Treatment , 1988, Developments in Oncology.

[22]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.